全文获取类型
收费全文 | 3315篇 |
免费 | 194篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 68篇 |
妇产科学 | 103篇 |
基础医学 | 339篇 |
口腔科学 | 71篇 |
临床医学 | 566篇 |
内科学 | 481篇 |
皮肤病学 | 33篇 |
神经病学 | 267篇 |
特种医学 | 41篇 |
外科学 | 211篇 |
综合类 | 75篇 |
一般理论 | 3篇 |
预防医学 | 395篇 |
眼科学 | 472篇 |
药学 | 218篇 |
中国医学 | 2篇 |
肿瘤学 | 150篇 |
出版年
2023年 | 17篇 |
2022年 | 23篇 |
2021年 | 45篇 |
2020年 | 36篇 |
2019年 | 73篇 |
2018年 | 60篇 |
2017年 | 39篇 |
2016年 | 54篇 |
2015年 | 62篇 |
2014年 | 61篇 |
2013年 | 137篇 |
2012年 | 197篇 |
2011年 | 232篇 |
2010年 | 135篇 |
2009年 | 120篇 |
2008年 | 189篇 |
2007年 | 187篇 |
2006年 | 198篇 |
2005年 | 186篇 |
2004年 | 166篇 |
2003年 | 119篇 |
2002年 | 138篇 |
2001年 | 30篇 |
2000年 | 31篇 |
1999年 | 23篇 |
1998年 | 34篇 |
1997年 | 33篇 |
1996年 | 24篇 |
1994年 | 20篇 |
1992年 | 25篇 |
1989年 | 24篇 |
1986年 | 19篇 |
1985年 | 27篇 |
1984年 | 21篇 |
1983年 | 16篇 |
1982年 | 18篇 |
1977年 | 16篇 |
1945年 | 23篇 |
1944年 | 21篇 |
1943年 | 25篇 |
1942年 | 28篇 |
1940年 | 24篇 |
1938年 | 30篇 |
1935年 | 25篇 |
1934年 | 27篇 |
1933年 | 31篇 |
1932年 | 41篇 |
1931年 | 30篇 |
1930年 | 19篇 |
1929年 | 28篇 |
排序方式: 共有3525条查询结果,搜索用时 15 毫秒
1.
Amanda Bolderston Jackie Middleton Cynthia Palmaria Susan Cauti Susan Fawcett 《Journal of Medical Imaging and Radiation Sciences》2021,52(2):160-163
Lesbian, gay, bisexual, transgender, queer and two-spirit plus (LGBTQ2S+) people have distinct healthcare needs that may be unaddressed in many undergraduate healthcare curricula. The Radiation Therapy Program (RADTH) at the University of Alberta underwent a review of the three-year didactic curriculum using an online survey. The survey sought to ascertain if, where and how topics related to LGBTQ2S + healthcare are taught. Results indicated that out of 10 RADTH program faculty respondents, three teach related topics. The total time dedicated within the three-year curriculum was approximately three and a half hours. Other findings showed that faculty are interested in receiving more education in this area and would favour discussions about how to incorporate these themes into appropriate courses. This preliminary investigation demonstrated that there has been some initial work in this area, but there is more to be done. 相似文献
2.
Susan C. Fox Jane A. May Natalia Dovlatova Jackie R. Glenn Andrew Johnson Ann E. White 《Platelets》2019,30(3):290-295
Measurement of P-selectin on activated platelets as a means of measuring platelet function utilizing the technology described here has the advantage of not requiring immediate access to specialist equipment and expertise. Blood samples are activated, fixed, stored, and transported to a central laboratory for flow cytometric analysis. Here we have compared P-selectin with other more traditional approaches to measuring platelet function in blood and/or platelet-rich plasma (PRP) from patients with acute coronary syndromes on treatment for at least 1 month with either aspirin and clopidogrel or aspirin with prasugrel. The comparators were light transmission aggregometry (LTA), VerifyNow and Multiplate aggregometry (for determining the effects of aspirin) and LTA, VerifyNow and Multiplate together with the BioCytex VASP phosphorylation assay (for the P2Y12 antagonists). The P-selectin Aspirin Test revealed substantial inhibition of platelet function in all but three of 96 patients receiving aspirin with clopidogrel and in none of 51 patients receiving aspirin and prasugrel. The results were very similar to those obtained using LTA. There was only one patient with high residual platelet aggregation and low P-selectin expression. The same patients identified as “non-responders” to aspirin also presented with the highest residual platelet activity as measured using the VerifyNow system, although not quite as well separated from the other values. With the Multiplate test only one of these patients clearly stood out from the others. The results obtained using the P-selectin P2Y12 Test in 102 patients taking aspirin and clopidogrel were similar to the more traditional approaches in that a wide scatter of results was obtained. Generally, high values seen with the P-selectin P2Y12 Test were also high with the LTA, VerifyNow, Multiplate, and BioCytex VASP P2Y12 Tests. Similarly, low residual platelet function using the P2Y12 test was seen irrespective of the testing procedure used. However, there were differences in some patients. Prasugrel was always more effective than clopidogrel in inhibiting platelet function with none of 56 patients (P-selectin and VerifyNow), only 2 of 56 patients (Multiplate) and only 3 of 56 patients (Biocytex VASP) demonstrating high on-treatment residual platelet reactivity (HRPR) defined using previously published cut-off values. The exception was LTA where there were 11 of 56 patients with HRPR. It remains to be seen which experimental approach provides the most useful information regarding outcomes after adjusting therapies in treated patients. 相似文献
3.
4.
N G Crisp C B Ijsselmuiden R De Swardt M M Steyn D M Gibbs E T Tshabalala 《Suid-Afrikaanse tydskrif vir geneeskunde》1987,72(5):345-348
Following the outbreak of poliomyelitis in Gazankulu in 1982, the immunisation services in Gazankulu were thoroughly examined. As a result of this, a comprehensive immunisation policy for Gazankulu was accepted in November 1986. The broad aim of the policy is to provide effective immunisation to all Gazankulu residents against tuberculosis, diphtheria, pertussis, tetanus, poliomyelitis and measles. A specific objective is that by the end of 1987, 85% of under-5s should have been vaccinated against these six diseases and by the end of 1990 this percentage should be 97%. The detailed strategies to reach these objectives are highlighted. Within the framework of the objectives, the policy allows different areas to formulate individual strategies. Programme monitoring and community involvement are two crucial aspects of the policy and these are discussed in detail. The early successes and difficulities in implementing this policy are discussed. 相似文献
5.
7.
Jackie Glover 《The Hastings Center report》1997,27(1):45-45
The Patient in the Family: An Ethics of Medicine and Families. By Hilde Lindemann Nelson and James Lindemann Nelson. 相似文献
8.
9.
10.